{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:55:36Z","timestamp":1792014936840,"version":"4.4.0"},"reference-count":127,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["106698\/Z\/14\/Z"],"award-info":[{"award-number":["106698\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Singapore National Medical Research Council Research Fellowship","award":["NMRC\/Fellowship\/0051\/2017"],"award-info":[{"award-number":["NMRC\/Fellowship\/0051\/2017"]}]},{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V028456\/1"],"award-info":[{"award-number":["MR\/V028456\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Reducing antibiotic duration is a key stewardship intervention to mitigate antimicrobial resistance (AMR). We examined current evidence informing antibiotic duration for common bacterial infections to identify any gaps in terms of settings, patient populations and infectious conditions. Trial methodologies were assessed to identify areas for improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>MEDLINE and Embase were searched up to July 2024 for randomized trials comparing antibiotic durations in hospital and community settings (PROSPERO 2021, CRD42021276209). A narrative synthesis of the results was performed with a review on the major guidelines published by IDSA, NICE, WHO and other international societies to assess the impact of these trials on practice guidance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 315 studies, 85% concluded equivalence or non-inferiority of shorter courses. Adult bacterial sinusitis, community-acquired pneumonia, female cystitis\/pyelonephritis, uncomplicated cellulitis and intra-abdominal infection with adequate source control and perioperative prophylaxis had robust evidence supporting shorter durations. Few trials studied severe infections, such as bloodstream infections and ventilator-associated pneumonia. Twenty-three (7%) of the trials were conducted in intensive care settings and only 43 trials (14%) enrolled patients from low-to-middle- or low-income countries. Only 15% of studies were at low risk for bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Reducing antibiotic duration likely remains an important strategy for antibiotic stewardship, and an area of active research. While shorter antibiotic courses may be suitable for many bacterial infections, more evidence is needed for severe infections and in low- and middle-income settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jacamr\/dlae215","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T07:17:02Z","timestamp":1737616622000},"source":"Crossref","is-referenced-by-count":27,"title":["Antibiotic duration for common bacterial infections\u2014a systematic review"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0216-9550","authenticated-orcid":false,"given":"Yin","family":"Mo","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, University Medicine Cluster, National University Hospital, Singapore ,","place":["Singapore"]},{"name":"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore ,","place":["Singapore"]},{"name":"Saw Swee Hock School of Public Health, National University of Singapore, Singapore ,","place":["Singapore"]},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford , Oxford ,","place":["UK"]},{"name":"Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University , Bangkok ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Cong","family":"Tan","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University Medicine Cluster, National University Hospital, Singapore ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben S","family":"Cooper","sequence":"additional","affiliation":[{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford , Oxford ,","place":["UK"]},{"name":"Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University , Bangkok ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"2025022008193944400_dlae215-B1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","article-title":"Understanding the mechanisms and drivers of antimicrobial resistance","volume":"387","author":"Holmes","year":"2016","journal-title":"Lancet"},{"key":"2025022008193944400_dlae215-B2","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.cmi.2017.08.026","article-title":"What is antimicrobial stewardship?","volume":"23","author":"Dyar","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"2025022008193944400_dlae215-B3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cmi.2018.11.002","article-title":"The quality of studies evaluating antimicrobial stewardship interventions: a systematic review","volume":"25","author":"Schweitzer","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2025022008193944400_dlae215-B4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1086\/526535","article-title":"The Maxwell Finland lecture: for the duration\u2014rational antibiotic administration in an era of antimicrobial resistance and Clostridium difficile","volume":"46","author":"Rice","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2025022008193944400_dlae215-B5","doi-asserted-by":"publisher","first-page":"j3418","DOI":"10.1136\/bmj.j3418","article-title":"The antibiotic course has had its day","volume":"358","author":"Llewelyn","year":"2017","journal-title":"BMJ"},{"key":"2025022008193944400_dlae215-B6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.21037\/atm.2017.04.04","article-title":"Biomarker-guided antibiotic therapy\u2014strengths and limitations","volume":"5","author":"Nora","year":"2017","journal-title":"Ann Transl Med"},{"key":"2025022008193944400_dlae215-B7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13643-017-0644-y","article-title":"Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study","volume":"6","author":"Bramer","year":"2017","journal-title":"Syst Rev"},{"key":"2025022008193944400_dlae215-B8","doi-asserted-by":"publisher","first-page":"l4898.","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2025022008193944400_dlae215-B9","first-page":"880","article-title":"Effectiveness and safety of short-course vs long-course antibiotic therapy for group A \u03b2-hemolytic streptococcal tonsillopharyngitis: a meta-analysis of randomized trials","volume-title":"Mayo Clin Proc","author":"Falagas","year":"2008"},{"key":"2025022008193944400_dlae215-B10","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1093\/cid\/cis629","article-title":"Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America","volume":"55","author":"Shulman","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2025022008193944400_dlae215-B11","article-title":"Sore throat (acute): antimicrobial prescribing, recommendations. NG84","author":"NICE","year":"2018"},{"key":"2025022008193944400_dlae215-B12","article-title":"The WHO AWaRe (Access, Watch, Reserve) antibiotic book","author":"WHO","year":"2022"},{"key":"2025022008193944400_dlae215-B13","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1128\/AAC.42.5.1073","article-title":"Five-day cefdinir treatment for streptococcal pharyngitis","volume":"42","author":"Tack","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2025022008193944400_dlae215-B14","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1086\/430307","article-title":"Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis","volume":"40","author":"Casey","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2025022008193944400_dlae215-B15","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3390\/antibiotics9110733","article-title":"Short- vs. long-course antibiotic treatment for acute streptococcal pharyngitis: systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Holm","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"2025022008193944400_dlae215-B16","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1056\/NEJMoa1606043","article-title":"Shortened antimicrobial treatment for acute otitis media in young children","volume":"375","author":"Hoberman","year":"2016","journal-title":"N Engl J Med"},{"key":"2025022008193944400_dlae215-B17","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1016\/j.ijid.2010.12.003","article-title":"Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin\/clavulanate for the treatment of children with acute otitis media","volume":"15","author":"Arguedas","year":"2011","journal-title":"Int J Infect Dis"},{"key":"2025022008193944400_dlae215-B18","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S0022-3476(98)70103-9","article-title":"A multicenter, randomized, double-blind trial of 5 versus 10 days of antibiotic therapy for acute otitis media in young children","volume":"133","author":"Cohen","year":"1998","journal-title":"J Pediatr"},{"key":"2025022008193944400_dlae215-B19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/00006454-199705000-00002","article-title":"Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin\/clavulanate potassium (Augmentin\u00ae) for treatment of acute otitis media in children","volume":"16","author":"Hoberman","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"2025022008193944400_dlae215-B20","doi-asserted-by":"publisher","first-page":"e964","DOI":"10.1542\/peds.2012-3488","article-title":"The diagnosis and management of acute otitis media","volume":"131","author":"Lieberthal","year":"2013","journal-title":"Pediatrics"},{"key":"2025022008193944400_dlae215-B21","article-title":"Otitis media (acute): antimicrobial prescribing, Recommendations. NG91","author":"NICE","year":"2018"},{"key":"2025022008193944400_dlae215-B22","doi-asserted-by":"publisher","first-page":"e035343","DOI":"10.1136\/bmjopen-2019-035343","article-title":"Clinical practice guidelines for acute otitis media in children: a systematic review and appraisal of European national guidelines","volume":"10","author":"Suzuki","year":"2020","journal-title":"BMJ Open"},{"key":"2025022008193944400_dlae215-B23","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMe1614712","article-title":"Acute Otitis Media\u2014The Long and the Short of It","author":"Kenna","year":"2016"},{"key":"2025022008193944400_dlae215-B24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1365-2125.2008.03306.x","article-title":"Effectiveness and safety of short vs. long duration of antibiotic therapy for acute bacterial sinusitis: a meta-analysis of randomized trials","volume":"67","author":"Falagas","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"2025022008193944400_dlae215-B25","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1542\/peds.2013-1071","article-title":"Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years","volume":"132","author":"Wald","year":"2013","journal-title":"Pediatrics"},{"key":"2025022008193944400_dlae215-B26","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1093\/cid\/cis370","article-title":"IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults","volume":"54","author":"Chow","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2025022008193944400_dlae215-B27","article-title":"Sinusitis (acute): antimicrobial prescribing, Recommendations NG79","author":"NICE","year":"2017"},{"key":"2025022008193944400_dlae215-B28","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.amjmed.2007.04.023","article-title":"Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis","volume":"120","author":"Li","year":"2007","journal-title":"Am J Med"},{"key":"2025022008193944400_dlae215-B29","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1136\/bmj.332.7554.1355","article-title":"Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study","volume":"332","author":"el Moussaoui","year":"2006","journal-title":"BMJ"},{"issue":"issue 4","key":"2025022008193944400_dlae215-B30","first-page":"CD005976","article-title":"Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months","author":"Haider","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"2025022008193944400_dlae215-B31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/INF.0000000000000023","article-title":"Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial","volume":"33","author":"Greenberg","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"2025022008193944400_dlae215-B32","article-title":"Pneumonia (community-acquired): antimicrobial prescribing, Recommendations NG138","author":"NICE","year":"2019"},{"key":"2025022008193944400_dlae215-B33","doi-asserted-by":"publisher","first-page":"e00635-18","DOI":"10.1128\/AAC.00635-18","article-title":"Systematic review and meta-analysis of the efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults","volume":"62","author":"Tansarli","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2025022008193944400_dlae215-B34","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2025022008193944400_dlae215-B35","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00134-023-07033-8","article-title":"ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia","volume":"49","author":"Martin-Loeches","year":"2023","journal-title":"Intensive Care Med"},{"key":"2025022008193944400_dlae215-B36","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03602.x","article-title":"Guidelines for the management of adult lower respiratory tract infections - full version","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"2025022008193944400_dlae215-B37","doi-asserted-by":"publisher","first-page":"CD009070","DOI":"10.1002\/14651858.CD009070.pub2","article-title":"Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients","volume":"9","author":"L\u00f3pez-Alcalde","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2025022008193944400_dlae215-B38","doi-asserted-by":"publisher","first-page":"e1123","DOI":"10.1093\/cid\/ciac374","article-title":"Antibiotic treatment duration for community-acquired pneumonia in outpatient children in high-income countries\u2014a systematic review and meta-analysis","volume":"76","author":"Kuitunen","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025022008193944400_dlae215-B39","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1001\/jama.2021.17843","article-title":"Effect of amoxicillin dose and treatment duration on the need for antibiotic re-treatment in children with community-acquired pneumonia","volume":"326","author":"Bielicki","year":"2021","journal-title":"JAMA"},{"key":"2025022008193944400_dlae215-B40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1001\/jamapediatrics.2021.5547","article-title":"Short- vs standard-course outpatient antibiotic therapy for community-acquired pneumonia in children","volume":"176","author":"Williams","year":"2022","journal-title":"JAMA Pediatr"},{"key":"2025022008193944400_dlae215-B41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1912400","article-title":"Amoxicillin for 3 or 5 days for chest-indrawing pneumonia in Malawian children","volume":"383","author":"Ginsburg","year":"2020","journal-title":"N Engl J Med"},{"key":"2025022008193944400_dlae215-B42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1056\/NEJMe2016328","article-title":"Antibiotics for childhood pneumonia\u2014do we really know how long to treat?","volume":"383","author":"Chang","year":"2020","journal-title":"N Engl J Med"},{"key":"2025022008193944400_dlae215-B43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5114\/ait.2021.104300","article-title":"Efficacy and safety of the point-of-care procalcitonin test for determining the antibiotic treatment duration in patients with ventilator-associated pneumonia in the intensive care unit: a randomised controlled trial","volume":"53","author":"Mazlan","year":"2021","journal-title":"Anaesthesiol Intensive Ther"},{"key":"2025022008193944400_dlae215-B44","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.annfar.2008.10.021","article-title":"Dur\u00e9e de l\u2019antibioth\u00e9rapie lors du traitement des pneumopathies acquises sous ventilation m\u00e9canique: comparaison entre sept jours et dix jours. \u00c9tude pilote","volume":"28","author":"Fekih Hassen","year":"2009","journal-title":"Ann Fr Anesth R\u00e9anim"},{"key":"2025022008193944400_dlae215-B45","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1183\/09031936.00053209","article-title":"Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study","volume":"34","author":"Stolz","year":"2009","journal-title":"Eur Respir J"},{"key":"2025022008193944400_dlae215-B46","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1378\/chest.125.5.1791","article-title":"A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia","volume":"125","author":"Micek","year":"2004","journal-title":"Chest"},{"key":"2025022008193944400_dlae215-B47","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial","volume":"290","author":"Chastre","year":"2003","journal-title":"JAMA"},{"key":"2025022008193944400_dlae215-B48","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S2213-2600(23)00418-6","article-title":"Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial","volume":"12","author":"Mo","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2025022008193944400_dlae215-B49","doi-asserted-by":"publisher","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","article-title":"International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociaci\u00f3n Latinoamericana del T\u00f3rax (ALAT)","volume":"50","author":"Torres","year":"2017","journal-title":"Eur Respir J"},{"key":"2025022008193944400_dlae215-B50","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"issue 8","key":"2025022008193944400_dlae215-B51","first-page":"CD007577","article-title":"Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults","author":"Pugh","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025022008193944400_dlae215-B52","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00134-022-06690-5","article-title":"Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial","volume":"48","author":"Bougl\u00e9","year":"2022","journal-title":"Intensive Care Med"},{"key":"2025022008193944400_dlae215-B53","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","article-title":"Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis","volume":"18","author":"Schuetz","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2025022008193944400_dlae215-B54","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1479972317745734","article-title":"Does antibiotic treatment duration affect the outcomes of exacerbations of asthma and COPD? A systematic review","volume":"15","author":"Stolbrink","year":"2018","journal-title":"Chron Respir Dis"},{"key":"2025022008193944400_dlae215-B55","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2025022008193944400_dlae215-B56","article-title":"Urinary tract infection (lower): antimicrobial prescribing, Recommendations. NG109","author":"NICE","year":"2018"},{"key":"2025022008193944400_dlae215-B57","article-title":"Urological Infections\u2014the Guideline","author":"European Association of Urology.","year":"2024"},{"key":"2025022008193944400_dlae215-B58","article-title":"Urinary tract infection (lower): antimicrobial prescribing, Summary of the evidence. NG109","author":"NICE","year":"2018"},{"key":"2025022008193944400_dlae215-B59","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/jama.2021.9899","article-title":"Effect of 7 vs 14 days of antibiotic therapy on resolution of symptoms among afebrile men with urinary tract infection: a randomized clinical trial","volume":"326","author":"Drekonja","year":"2021","journal-title":"JAMA"},{"key":"2025022008193944400_dlae215-B60","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1093\/cid\/ciad070","article-title":"Antimicrobial for 7 or 14 days for febrile urinary tract infection in men: a multicenter noninferiority double-blind, placebo-controlled, randomized clinical trial","volume":"76","author":"Lafaurie","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025022008193944400_dlae215-B61","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.urology.2007.09.002","article-title":"A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400\/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis","volume":"71","author":"Peterson","year":"2008","journal-title":"Urology"},{"key":"2025022008193944400_dlae215-B62","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.apmr.2013.09.003","article-title":"Short versus long course of antibiotics for catheter-associated urinary tract infections in patients with spinal cord injury: a randomized controlled noninferiority trial","volume":"95","author":"Darouiche","year":"2014","journal-title":"Arch Phys Med Rehabil"},{"key":"2025022008193944400_dlae215-B63","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/S0022-5347(05)67150-9","article-title":"Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection","volume":"164","author":"Raz","year":"2000","journal-title":"J Urol"},{"key":"2025022008193944400_dlae215-B64","article-title":"Urinary tract infection (catheter-associated): antimicrobial prescribing, Recommendations. NG113","author":"NICE.","year":"2018."},{"key":"2025022008193944400_dlae215-B65","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1086\/650482","article-title":"Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America","volume":"50","author":"Hooton","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2025022008193944400_dlae215-B66","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1001\/jama.283.12.1583","article-title":"Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial","volume":"283","author":"Talan","year":"2000","journal-title":"JAMA"},{"key":"2025022008193944400_dlae215-B67","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa2020198","article-title":"Antibiotic therapy for 6 or 12 weeks for prosthetic joint infection","volume":"384","author":"Bernard","year":"2021","journal-title":"N Engl J Med"},{"key":"2025022008193944400_dlae215-B68","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cis966","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2025022008193944400_dlae215-B69","article-title":"Musculoskeletal system infections, antimicrobial therapy, Treatment summaries","author":"NICE, BNF.","year":"2020"},{"key":"2025022008193944400_dlae215-B70","article-title":"Joint replacement (primary): hip, knee and shoulder, Recommendations. NG157","author":"NICE","year":"2020"},{"key":"2025022008193944400_dlae215-B71","article-title":"Surgical site infections: prevention and treatment, Recommendations. NG125","author":"NICE","year":"2019"},{"key":"2025022008193944400_dlae215-B72","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2025022008193944400_dlae215-B73","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/00006231-200608000-00007","article-title":"Osteomyelitis: clinical update for practical guidelines","volume":"27","author":"Concia","year":"2006","journal-title":"Nucl Med Commun"},{"key":"2025022008193944400_dlae215-B74","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5194\/jbji-8-29-2023","article-title":"Guideline for management of septic arthritis in native joints (SANJO)","volume":"8","author":"Ravn","year":"2023","journal-title":"J Bone Jt Infect"},{"key":"2025022008193944400_dlae215-B75","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/antibiotics11040486","article-title":"Antibiotic therapy for prosthetic joint infections: an overview","volume":"11","author":"Le Vavasseur","year":"2022","journal-title":"Antibiotics"},{"key":"2025022008193944400_dlae215-B76","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.arth.2019.11.026","article-title":"The role of long-term antibiotic suppression in the management of peri-prosthetic joint infections treated with debridement, antibiotics, and implant retention: a systematic review","volume":"35","author":"Malahias","year":"2020","journal-title":"J Arthroplasty"},{"key":"2025022008193944400_dlae215-B77","doi-asserted-by":"publisher","first-page":"e1539","DOI":"10.1093\/cid\/ciaa1758","article-title":"Three weeks versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: a prospective, randomized, noninferiority pilot trial","volume":"73","author":"Gariani","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025022008193944400_dlae215-B78","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/1534734615596891","article-title":"Can we stop antibiotic therapy when signs and symptoms have resolved in diabetic foot infection patients?","volume":"14","author":"Chu","year":"2015","journal-title":"Int J Low Extrem Wounds"},{"key":"2025022008193944400_dlae215-B79","doi-asserted-by":"publisher","first-page":"302","DOI":"10.2337\/dc14-1514","article-title":"Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study","volume":"38","author":"Tone","year":"2014","journal-title":"Diabetes Care"},{"key":"2025022008193944400_dlae215-B80","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(14)61233-2","article-title":"Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial","volume":"385","author":"Bernard","year":"2015","journal-title":"Lancet"},{"key":"2025022008193944400_dlae215-B81","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1136\/annrheumdis-2019-215116","article-title":"Two weeks versus four weeks of antibiotic therapy after surgical drainage for native joint bacterial arthritis: a prospective, randomised, non-inferiority trial","volume":"78","author":"Gjika","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2025022008193944400_dlae215-B82","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1093\/jac\/dkz166","article-title":"Short-course versus long-course antibiotics in prosthetic joint infections: a systematic review and meta-analysis of one randomized controlled trial plus nine observational studies","volume":"74","author":"Yen","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2025022008193944400_dlae215-B83","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1086\/597582","article-title":"Prospective, randomized trial of 10 days versus 30 days of antimicrobial treatment, including a short-term course of parenteral therapy, for childhood septic arthritis","volume":"48","author":"Peltola","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2025022008193944400_dlae215-B84","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/ijms17060855","article-title":"Update on the management of pediatric acute osteomyelitis and septic arthritis","volume":"17","author":"Castellazzi","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2025022008193944400_dlae215-B85","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/jpc.12251","article-title":"Systematic review of duration and choice of systemic antibiotic therapy for acute haematogenous bacterial osteomyelitis in children","volume":"49","author":"Howard-Jones","year":"2013","journal-title":"J Paediatr Child Health"},{"key":"2025022008193944400_dlae215-B86","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1097\/INF.0b013e3181f55a89","article-title":"Short- versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture-positive cases","volume":"29","author":"Peltola","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"2025022008193944400_dlae215-B87","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","article-title":"Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial","volume":"69","author":"Yahav","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025022008193944400_dlae215-B88","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1001\/jama.2020.6348","article-title":"Effect of C-reactive protein\u2013guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated gram-negative bacteremia: a randomized clinical trial","volume":"323","author":"von Dach","year":"2020","journal-title":"JAMA"},{"key":"2025022008193944400_dlae215-B89","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12098-021-03794-6","article-title":"Ten versus 14 days of antibiotic therapy in culture-proven neonatal sepsis: a randomized, controlled trial","volume":"89","author":"Reddy","year":"2022","journal-title":"Indian J Pediatr"},{"key":"2025022008193944400_dlae215-B90","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/jpc.13518","article-title":"Seven versus 10 days antibiotic therapy for culture-proven neonatal sepsis: a randomised controlled trial","volume":"53","author":"Rohatgi","year":"2017","journal-title":"J Paediatr Child Health"},{"key":"2025022008193944400_dlae215-B91","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1001\/jama.2018.13155","article-title":"Effect of algorithm-based therapy vs usual care on clinical success and serious adverse events in patients with staphylococcal bacteremia: a randomized clinical trial","volume":"320","author":"Holland","year":"2018","journal-title":"JAMA"},{"key":"2025022008193944400_dlae215-B92","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.cmi.2020.01.003","article-title":"Duration of antibiotic therapy for Staphylococcus aureus bacteraemia: the long and the short of it","volume":"26","author":"Eichenberger","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2025022008193944400_dlae215-B93","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1093\/eurheartj\/ehad625","article-title":"2023 ESC guidelines for the management of endocarditis: developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM)","volume":"44","author":"Delgado","year":"2023","journal-title":"Eur Heart J"},{"key":"2025022008193944400_dlae215-B94","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"key":"2025022008193944400_dlae215-B95","doi-asserted-by":"publisher","first-page":"e963","DOI":"10.1161\/CIR.0000000000000969","article-title":"Prevention of Viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association","volume":"143","author":"Wilson","year":"2021","journal-title":"Circulation"},{"key":"2025022008193944400_dlae215-B96","article-title":"Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures, Recommendations. CG64","author":"NICE","year":"2008"},{"key":"2025022008193944400_dlae215-B97","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1136\/adc.2008.151563","article-title":"Short versus long duration of antibiotic therapy for bacterial meningitis: a meta-analysis of randomised controlled trials in children","volume":"94","author":"Karageorgopoulos","year":"2009","journal-title":"Arch Dis Child"},{"key":"2025022008193944400_dlae215-B98","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/jac\/46.2.255","article-title":"Comparative efficacy of 5 days of dirithromycin and 7 days of erythromycin in skin and soft tissue infections","volume":"46","author":"Wasilewski","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"2025022008193944400_dlae215-B99","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1001\/archinte.164.15.1669","article-title":"Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis","volume":"164","author":"Hepburn","year":"2004","journal-title":"Arch Intern Med"},{"key":"2025022008193944400_dlae215-B100","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cmi.2019.09.019","article-title":"Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial","volume":"26","author":"Cranendonk","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2025022008193944400_dlae215-B101","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1001\/jama.2013.241","article-title":"Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial","volume":"309","author":"Prokocimer","year":"2013","journal-title":"JAMA"},{"key":"2025022008193944400_dlae215-B102","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/cid\/civ982","article-title":"A randomized clinical trial of single-dose versus weekly dalbavancin for treatment of acute bacterial skin and skin structure infection","volume":"62","author":"Dunne","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025022008193944400_dlae215-B103","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4103\/0253-7613.161254","article-title":"Comparative evaluation of 2 g single dose versus conventional dose azithromycin in uncomplicated skin and skin structure infections","volume":"47","author":"Dey","year":"2015","journal-title":"Indian J Pharmacol"},{"key":"2025022008193944400_dlae215-B104","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/cid\/ciu778","article-title":"Single-dose oritavancin versus 7\u201310 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study","volume":"60","author":"Corey","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2025022008193944400_dlae215-B105","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2025022008193944400_dlae215-B106","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/sur.2009.9930","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"11","author":"Solomkin","year":"2010","journal-title":"Surg Infect (Larchmt)"},{"key":"2025022008193944400_dlae215-B107","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1056\/NEJMoa1411162","article-title":"Trial of short-course antimicrobial therapy for intraabdominal infection","volume":"372","author":"Sawyer","year":"2015","journal-title":"N Engl J Med"},{"key":"2025022008193944400_dlae215-B108","article-title":"Global Guidelines for the Prevention of Surgical Site Infection, 2nd ed","author":"WHO","year":"2018"},{"key":"2025022008193944400_dlae215-B109","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1445-2197.1998.tb04785.x","article-title":"Single-versus multiple\u2013dose antimicrobial prophylaxis for major surgery: a systematic review","volume":"68","author":"McDonald","year":"1998","journal-title":"Aust N Z J Surg"},{"key":"2025022008193944400_dlae215-B110","doi-asserted-by":"publisher","first-page":"943","DOI":"10.7326\/0003-4819-76-6-943","article-title":"Antibiotic prophylaxis and cardiac surgery","volume":"76","author":"Conte","year":"1972","journal-title":"Ann Intern Med"},{"key":"2025022008193944400_dlae215-B111","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1136\/bmj.1.6165.707","article-title":"Antibiotic prophylaxis in total hip replacement","volume":"1","author":"Pollard","year":"1979","journal-title":"Br Med J"},{"key":"2025022008193944400_dlae215-B112","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1161\/01.CIR.101.25.2916","article-title":"Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance","volume":"101","author":"Harbarth","year":"2000","journal-title":"Circulation"},{"key":"2025022008193944400_dlae215-B113","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1017\/ice.2017.158","article-title":"Antibiotic overuse is a major risk factor for Clostridium difficile infection in surgical patients","volume":"38","author":"Bernatz","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2025022008193944400_dlae215-B114","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1001\/jamasurg.2019.0569","article-title":"Association of duration and type of surgical prophylaxis with antimicrobial-associated adverse events","volume":"154","author":"Branch-Elliman","year":"2019","journal-title":"JAMA Surg"},{"key":"2025022008193944400_dlae215-B115","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1089\/sur.2013.9999","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"14","author":"Bratzler","year":"2013","journal-title":"Surg Infect (Larchmt)"},{"key":"2025022008193944400_dlae215-B116","article-title":"Peri-operative antimicrobial prophylaxis","author":"ECDC","year":"2017"},{"key":"2025022008193944400_dlae215-B117","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cmi.2022.12.012","article-title":"ESCMID\/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery","volume":"29","author":"Righi","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2025022008193944400_dlae215-B118","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","article-title":"Association of adverse events with antibiotic use in hospitalized patients","volume":"177","author":"Tamma","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2025022008193944400_dlae215-B119","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13223-020-0402-x","article-title":"Antibiotic hypersensitivity and adverse reactions: management and implications in clinical practice","volume":"16","author":"Jourdan","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"key":"2025022008193944400_dlae215-B120","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1745-6215-12-106","article-title":"Through the looking glass: understanding non-inferiority","volume":"12","author":"Schumi","year":"2011","journal-title":"Trials"},{"key":"2025022008193944400_dlae215-B121","doi-asserted-by":"publisher","first-page":"S249","DOI":"10.1086\/591411","article-title":"Position paper: Recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia","volume":"47","author":"Spellberg","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2025022008193944400_dlae215-B122","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1016\/j.jacc.2005.07.062","article-title":"Trials and tribulations of non-inferiority: the ximelagatran experience","volume":"46","author":"Kaul","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2025022008193944400_dlae215-B123","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12916-019-1348-z","article-title":"Optimising trial designs to identify appropriate antibiotic treatment durations","volume":"17","author":"Pouwels","year":"2019","journal-title":"BMC Med"},{"key":"2025022008193944400_dlae215-B124","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1111\/iju.15045","article-title":"Prospective randomized trial of 2 versus 12-weeks of postoperative antibiotics after percutaneous nephrolithotomy in complex patients with infection-related kidney stones","volume":"29","author":"Chew","year":"2022","journal-title":"Int J Urol"},{"key":"2025022008193944400_dlae215-B125","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000282164","article-title":"Single-dose fosfomycin trometamol (Monuril) versus multiple-dose norfloxacin: results of a multicenter study in females with uncomplicated lower urinary tract infections","volume":"46","author":"de Jong","year":"1991","journal-title":"Urol Int"},{"key":"2025022008193944400_dlae215-B126","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1128\/AAC.32.8.1292","article-title":"Double-blind, randomized comparison of 24 weeks of norfloxacin and 12 weeks of norfloxacin followed by 12 weeks of placebo in the therapy of complicated urinary tract infection","volume":"32","author":"Sheehan","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"2025022008193944400_dlae215-B127","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/bmj.3.5975.65","article-title":"Duration of treatment for urinary tract infections in children","volume":"3","author":"Stansfeld","year":"1975","journal-title":"Br Med J"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/7\/1\/dlae215\/61667162\/dlae215.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/7\/1\/dlae215\/61667162\/dlae215.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T03:22:41Z","timestamp":1740021761000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlae215\/7986017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":127,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,26]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlae215","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,12,26]]},"article-number":"dlae215"}}